Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Financials · ·
$399.07
▼ $5.19 (-1.3%)
Market data updated: 09/18 07:52 PM
Fundamentals updated: 09/18/2026
News analyzed: 09/18/2026
Market Cap
$26.20B
Day Range
$396.39 - $403.21
52-Week Range
$252.84 - $427.46
Beta
—
Next Earnings
02.11.2026
CPAY is a stock from the Financials sector — Banks, insurance, and asset management — profitability sensitive to interest rates and credit cycles.
+30.1% (1Y)
Strengths: 10/31 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
DCF Fair Value
Estimated fair value: $185.52 vs. price $399.07 (-53.5%)
Fair Value
What to watch next
When today echoes the past.
87/100
Similarity
15
Historical Matches
92/100
Analog Quality
+3.0%
Median 40D Outcome
62/100
Pattern Consistency
🟢 Bullish
60%
+4.0% … +8.2%
🟡 Base
7%
-0.7% … -0.7%
🔴 Bearish
33%
-10.5% … -5.5%
Typical timeframe (based on real historical rates clearing a 60% bar): 20 trading days.
📌 Bottom line: Out of 15 similar historical cases for this stock, 60% (95% CI 36%–80%) saw the stock rise within 20 trading days, with a median gain of +3.0%.
Echo #1 — Trend Acceleration
4 occurrence(s) · 25% historical success
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 27% (11%–52%) | -0.9% | -4.2% … +1.5% | +0.4% |
| 10D | 47% (25%–70%) | +0.6% | -4.2% … +3.0% | +1.1% |
| 20D | 60% (36%–80%) | +3.0% | -4.5% … +6.2% | +1.7% |
| 40D | 60% (36%–80%) | +3.0% | -6.4% … +7.4% | +3.0% |
| 60D | 53% (30%–75%) | +1.1% | -5.9% … +6.1% | +4.2% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2018-03-22 | 87/100 | Consolidation | +3.0% | +8.7% |
| 2024-04-12 | 86/100 | ✓ Uptrend | -5.5% | -8.9% |
| 2023-07-31 | 86/100 | Consolidation | +8.8% | -3.3% |
| 2024-05-02 | 86/100 | Consolidation | -10.5% | -0.4% |
| 2019-07-31 | 85/100 | Uptrend | +4.0% | +4.2% |
| 2024-12-11 | 84/100 | Uptrend | -3.5% | -8.5% |
| 2018-05-24 | 84/100 | Consolidation | +6.9% | +6.3% |
| 2019-12-12 | 84/100 | Consolidation | -0.7% | -26.2% |
| 2025-02-14 | 84/100 | Uptrend | -8.0% | -6.0% |
| 2026-06-22 | 83/100 | Uptrend | +5.5% | +15.9% |
| 2018-06-11 | 83/100 | Consolidation | +8.2% | +5.9% |
| 2019-10-07 | 83/100 | Consolidation | +3.0% | +1.1% |
| 2021-03-26 | 83/100 | Uptrend | +4.6% | -5.8% |
| 2024-09-25 | 82/100 | Uptrend | +16.3% | +11.3% |
| 2023-09-22 | 82/100 | ✓ Uptrend | -11.5% | +3.0% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLF (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
53
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
53
Quality
58
Value
38
Momentum
47
Risk
28
Sentiment
80
Fundamental
60
Institutional
0
Stocks with a similar DNA right now
SCANNING CPAY...
Recent media coverage of **Corpay (CPAY)** has focused on its strong financial performance and strategic shifts. The company reported a 21% revenue increase and a 36% rise in adjusted EPS for Q2 2026, beating expectations, while simplifying operations by selling a non-core UK fleet software business. Analysts, including Scotiabank, upgraded Corpay to "Outperform" with a $536 price target, citing sustained organic growth, a positive 2026 outlook, and aggressive share buybacks. The stock has risen 15% over three months, reflecting investor confidence.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Corpay. News trend score: 80. Reason: 8 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
34
🎯 Conviction (vs. Emotion)
41
Psychology
45
Fundamentals
60
Technical
47
Valuation
38
The price rise has far outpaced the actual improvement in fundamental data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price (3M)
+17%
Market Narrative
69
Fundamental Reality
41
Narrative Gap
+28
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
Market behavior suggests dominant herd behavior, as CPAY’s recent decline mirrors peer movements (-2.2% vs. -1.4%), implying passive alignment rather than aggressive action. The narrative gap (26 points) hints at a disconnect between optimistic sentiment (euphoria/overconfidence) and weak technical momentum, which may reflect overvaluation (+119% DCF) without fundamental justification. The key question is whether traders will sustain herd-like selling or reassess valuations as momentum remains negative. Low panic or FOMO scores indicate no extreme emotional triggers are driving the move.
Updated: 09/09/2026, 09:07 AM
What could change this?
👥 What the crowd believes
"Revenue climbed 21% to $1,338.8 million and adjusted earnings per share jumped 36% to $7.00"
"Scotiabank initiates coverage on Corpay (NYSE:CPAY) with a Sector Outperform rating and announces Price Target of $536"
"CPAY Stock Rises 15% in 3 Months: Here's What You Should Know — Corpay's sustained organic growth... and aggressive buybacks are supporting continued earnings momentum"
"Corpay agreed to sell a UK fleet software business it no longer sees as core"
📈 12D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 83/100
🔴 Weakest match
Benjamin Graham — 0/100
🗣️ Why do they disagree?
This stock’s divergent verdicts reflect stark contrasts in methodology priorities. The higher-scoring approaches—like Malkiel and Bogle’s efficient-market view or Fisher’s quality assessment—suggest it’s a *marginal* pick, at best, with only modest evidence of outperformance or exceptional traits. Meanwhile, the more conservative frameworks—Graham’s defensive criteria or Bagehot’s liquidity concerns—reject it outright, flagging structural risks or valuation gaps. The middle-ground thinkers (e.g., Marks, Loeb) warn of cyclical overreach or excessive volatility, while Lynch’s growth-at-a-reasonable-price filter and Veblen’s profit skepticism further dampen enthusiasm. The spread from a 62 to a 0 underscores how the stock’s perceived appeal hinges entirely on the investor’s risk tolerance and core assumptions—whether they prioritize passive exposure, growth potential, or ironclad fundamentals.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 83
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 56
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 55
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 52
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 49
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 48
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 41
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 40
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 36
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 28
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 26
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 22
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🔴 21
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 8
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 5
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 0
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (4 bullish · 7 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
78.6%
Operating Margin
44.0%
Net Margin
23.6%
EBITDA Margin
—
ROE
27.6%
ROA
4.0%
ROIC
—
EPS
$15.23
Cash
$2.41B
Total Debt
$13.35B
Current Ratio
0.98
Debt/Equity
2.58
How is Fair Value calculated? →
Current Price
$399.07
Estimated Fair Value (DCF)
$185.52
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-53.5%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
9.8%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 9.8% | $1.43B | $1.31B |
| 2 | 8.0% | $1.54B | $1.30B |
| 3 | 6.1% | $1.63B | $1.26B |
| 4 | 4.3% | $1.71B | $1.21B |
| 5 | 2.5% | $1.75B | $1.14B |
Base FCF (last actual year)
$1.30B
Terminal Value
$27.56B
Present Value of Terminal Value
$17.91B
Enterprise Value
$24.12B
Net Debt
$10.94B
Equity Value
$13.18B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$56.81
Tangible Book Value per Share (Tangible NAV)
$9.45
Sentiment based on basic keywords (not AI) — 8 positive, 9 neutral, 3 negative out of the last 20 articles.
Benzinga · 17.9.2026
ChartMill · 15.9.2026
StockStory · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 10.9.2026
Zacks · 10.9.2026
SeekingAlpha · 10.9.2026
Yahoo · 8.9.2026
StockStory · 8.9.2026
Yahoo · 4.9.2026
Zacks · 4.9.2026
Fintel · 3.9.2026
Yahoo · 2.9.2026
Benzinga · 2.9.2026
Zacks · 2.9.2026
MT Newswires · 2.9.2026
Yahoo · 2.9.2026
Insider Monkey · 2.9.2026
Yahoo · 1.9.2026
MT Newswires · 1.9.2026
Corpay (CPAY) currently has a StockIQ AI score of 53/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
CPAY currently scores 53/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, CPAY's estimated fair value is $185.52, which is 53.5% below the current price of $399.07. This is one valuation model among several signals in the fair-value category, not a price target.
CPAY's technical score is 47/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; Return on equity (ROE): 27.6% — strong; Price is above the 50-day average.
Based on the real signals StockIQ computed: Estimated fair value: $185.52 vs. price $399.07 (-53.5%); Current ratio: 0.98; Calmar: 0.40 (3y annualized return 13.7% / max drawdown 34.5%).
StockIQ has no recorded dividend payment history for CPAY.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 25 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,388,774 | -50,504 | $412.59 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,466,962 | -6,854 | $409.56 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,364,104 | -24,670 | $413.42 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,354,330 | -193 | $415.11 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,354,523 | -9,581 | $414.57 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,454,853 | -12,109 | $410.56 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 2,439,278 | -15,575 | $411.49 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 193 | -193 | $415.11 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 15,575 | -15,575 | $411.49 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 9,581 | -9,581 | $414.57 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 24,670 | -24,670 | $413.42 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 50,504 | -50,504 | $412.59 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 12,109 | -12,109 | $410.56 |
| Clarke Ronald | Open Market Sale | 25.8.2026 | 6,854 | -6,854 | $409.56 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,485,440 | -8,409 | $417.29 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,477,895 | -7,545 | $418.08 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,473,856 | -4,039 | $418.86 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,473,816 | -40 | $419.62 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,510,389 | -51,919 | $415.12 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,493,849 | -16,540 | $415.82 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 2,562,308 | -5,882 | $414.16 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 51,919 | -51,919 | $415.12 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 16,540 | -16,540 | $415.82 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 4,039 | -4,039 | $418.86 |
| Clarke Ronald | Open Market Sale | 24.8.2026 | 7,545 | -7,545 | $418.08 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
2,732,137 shares short as of 2026-08-31 · vs. 2,582,997 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
66.9% of trading volume this week was short selling, vs. 67.6% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology